“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas

Схожие документы

• Omics and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas.
  по: Elda eTagliabue, et al.
  Опубликовано: (2014-11-01)
• Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours
  по: Casalini, P, et al.
  Опубликовано: (2001)
• Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
  по: Rybinska, Ilona, et al.
  Опубликовано: (2020)
• Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing
  по: Agresti, R, et al.
  Опубликовано: (2001)
• Optimizing the management of her2-positive early breast cancer: the clinical reality
  по: Verma, Su., et al.
  Опубликовано: (2010)